Skip to main content
Top

Cancer Immunology, Immunotherapy

Issue 8/2004

Content (12 Articles)

Opinion Paper

How should clinical data be included in experimental studies of cancer immunology?

Bjørn Tore Gjertsen, Øystein Bruserud

Original Article

The effect of LIGHT in inducing maturation of monocyte-derived dendritic cells from MDS patients

Gang-Ming Zou, Jeff Martinson, Wen-Yang Hu, Ying Tam, Hans G. Klingemann

Original Article

Antitumor effects of fusions composed of dendritic cells and fibroblasts transfected with genomic DNA from tumor cells

Motoyuki Nakamura, Tetsuro Kikuchi, Donald W. Kufe, Tsuneya Ohno

Original Article

CpG-Oligodeoxynucleotides activate tyrosinase-related protein 2–specific T lymphocytes but do not lead to a protective tumor-specific memory response

Lucia Sfondrini, Dario Besusso, Vincenzo Bronte, Beatrice Macino, Anna Rossini, Mario Paolo Colombo, Sylvie Ménard, Andrea Balsari

Original Article

Generation of dendritic cell–tumor cell hybrids by electrofusion for clinical vaccine application

Katrina T. Trevor, Cathleen Cover, Yvette W. Ruiz, Emmanuel T. Akporiaye, Evan M. Hersh, Didier Landais, Rachel R. Taylor, Alan D. King, Richard E. Walters

Original Article

Analysis of T-cell responses in metastatic melanoma patients vaccinated with dendritic cells pulsed with tumor lysates

Marieke Griffioen, Martina Borghi, Peter I. Schrier, Susanne Osanto, Dirk Schadendorf

Original Article

Anandamide is an endogenous inhibitor for the migration of tumor cells and T lymphocytes

Jan Joseph, Bernd Niggemann, Kurt S. Zaenker, Frank Entschladen

Original Article

Leukocyte orchestration in blood and tumour tissue following interleukin-2 based immunotherapy in metastatic renal cell carcinoma

Frede Donskov, Karen Marie Bennedsgaard, Marianne Hokland, Niels Marcussen, Rune Fisker, Hans Henrik Torp Madsen, Kirsten Fode, Hans von der Maase

Original Article

Functional characterization of T lymphocytes derived from patients with acute myelogenous leukemia and chemotherapy-induced leukopenia

Øystein Wendelbo, Ingerid Nesthus, Malvin Sjo, Kristin Paulsen, Peter Ernst, Øystein Bruserud

Original Article

An epigenetically altered tumor cell vaccine

A. Nazmul H. Khan, William J. Magner, Thomas B. Tomasi

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine